Conversely, supplementation with exogenous recombinant Klotho or Klotho overexpression show improved health conditions in mouse models of the lung–kidney axis [40,41], cognitive impairment [42,43], sepsis [44], and pulmonary hypertension [45]. This evidence concerns the gene KL and pulmonary hypertension.